Latest stories on CRIS
CURIS INC (CRIS) files 8-K
SEC 8-K34 · bearishgeneral
Curis Doses First Five Patients in TakeAim CLL Study
PR Newswire63 · neutralproduct/pr
Curis Doses First Five Patients in TakeAim CLL Study
StockTitan63 · neutralproduct/pr
Curis, Inc. (CRIS) Discusses Positive Data From Emavusertib Combination Study in Primary CNS Lymphoma Transcript
Seeking Alpha73 · bullishproduct/pr
Curis shares surge after updated emavusertib data strengthens clinical outlook (NASDAQ:CRIS)
InvestorsHub71 · bullishproduct/pr
Curis Announces Positive Emavusertib Update
PR Newswire67 · bullishproduct/pr
Curis Consents First Six Patients in TakeAim CLL Study | CRIS Stock News
StockTitan63 · neutralproduct/pr
Curis Consents First Six Patients in TakeAim CLL Study
PR Newswire63 · neutralproduct/pr
CURIS INC (CRIS) files 8-K
SEC 8-K50 · neutralgeneral
8-K/A - CURIS INC (CRIS) files 8-K
SEC 8-K50 · neutralgeneral
Curis opens 11 sites for emavusertib combo in TakeAim CLL trial
Yahoo Finance63 · neutralproduct/pr
CURIS INC (CRIS) files 8-K
SEC 8-K50 · neutralgeneral
Curis Provides First Quarter 2026 Business Update
PR Newswire50 · neutralgeneral